Previous 10 | Next 10 |
2023-08-29 09:05:33 ET More on TScan Therapeutics TScan Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation TScan gains as FDA clears studies for T cell therapy candidate TScan Therapeutics stock slides on pricing $140M securities offering TScan...
WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that the U.S. Fo...
2023-08-10 10:15:14 ET TScan Therapeutics press release ( NASDAQ: TCRX ): Q2 GAAP EPS of -$0.51. Revenue of $3.1M (-24.4% Y/Y). For further details see: TScan Therapeutics GAAP EPS of -$0.51, revenue of $3.1M
Presented preliminary Phase 1 clinical data from heme malignancies trial at the ASGCT 26 th Annual Meeting; expect to reach recommended Phase 2 dose for two TCR-T therapy product candidates and report interim data by year-end 2023 Announced FDA clearance of fourth IND for solid tumo...
2023-06-29 07:05:55 ET TScan Therapeutics ( NASDAQ: TCRX ) CFO Brian M. Silver, J.D., will be leaving the Company, effective July 21, 2023, to pursue a new opportunity at a leading advisory firm based in New York. Brian will continue to be available to provide strategic a...
WALTHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-Ts) for the treatment of patients with cancer, today announced that its Chief ...
2023-06-21 17:18:56 ET Gainers: Root ( ROOT ) +37% . Applied Optoelectronics ( AAOI ) +11% . TScan Therapeutics ( TCRX ) +6% . Nkarta ( NKTX ) +4% . GoodRx Holdings ( GDRX ) +4% . Losers: AlloVir ( ALVR ) -18% . ...
2023-06-07 10:01:47 ET Gainers: Avrobio ( AVRO ) +10% . Cardiff Oncology ( CRDF ) +8% . IceCure Medical ( ICCM ) +7% . Humacyte ( HUMA ) +6% . TScan Therapeutics ( TCRX ) +4% . Losers: Vaxart ( VXRT ) -27% . Carism...
2023-06-06 10:05:06 ET Gainers: Hoth Therapeutics ( HOTH ) +114% . Zura Bio ( ZURA ) +15% . TScan Therapeutics ( TCRX ) +12% . HealthEquity ( HQY ) +11% . ThermoGenesis ( THMO ) +7% . Losers: HTG Molecular Diagnostics ( ...
WALTHAM, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-Ts) for the treatment of patients with cancer, today announced that the U.S. F...
News, Short Squeeze, Breakout and More Instantly...
TScan Therapeutics Inc. Company Name:
TCRX Stock Symbol:
NYSE Market:
TScan Therapeutics Inc. Website:
2024-07-16 12:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-26 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Garry A. Nicholson, an experienced executive with regulatory and commercial expertise, joins the Board of Directors Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role of Chair WALTHAM, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. ...